Today before the opening bell, Cord Blood America, Inc. announced the execution of an exclusive agreement to store stem cells at its Las Vegas laboratory for the National Children’s Leukemia Foundation (NCLF), New York.
“The National Children’s Leukemia Foundation has a track record of success in individual counseling and medical referrals for thousands of patients, providing them financial assistance for housing, food and transportation, supporting scientists working on cutting-edge research, and arranging flights, medical care and hospitality for international patients in need of medical care in the U.S,” stated Matthew Schissler, Cord Blood America CEO and co-founder. “We are pleased to be chosen by the NCLF for its storage needs.”
“Many lives have been saved, many wishes have been granted and many patients have benefited from our referrals and advocacy efforts in the two decades since our establishment,” commented Yehuda Gutwein, NCLF President. “We also are pleased to sign this exclusive agreement because we are aware of both the quality of the personnel and the care taken in storage by Cord Blood America.”
“It’s an honor to move our relationship from speaking about the benefits for children with leukemia, to storing stem cells for these same children,” added Lea Ann Stiller, representative of Cord Blood America and featured speaker for National Children’s Leukemia Foundation.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment